Mechanisms that determine plasma cell lifespan and the duration of humoral immunity

Immunological Reviews

Volumn 236, Issue 1, 2010, Pages 125-138

  Amanna, Ian J ^a   Slifka, Mark K ^b  

^a Najít Technologies Inc   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antibody; Immunological memory; Memory B cell; Plasma cell

Indexed keywords

B LYMPHOCYTE RECEPTOR; DIPHTHERIA VACCINE; EPSTEIN BARR VIRUS VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; TOLL LIKE RECEPTOR; VACCINIA VACCINE; VARICELLA ZOSTER VACCINE;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; CELL SURVIVAL; CHICKENPOX; DIPHTHERIA; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOSTIMULATION; MEASLES; MEMORY CELL; MUMPS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REVIEW; RUBELLA; T LYMPHOCYTE ACTIVATION; TETANUS; VACCINATION; VACCINIA;

ANIMALS; ANTIBODIES; ANTIGENS; CELL SURVIVAL; HUMANS; IMMUNITY, HUMORAL; MODELS, IMMUNOLOGICAL; PLASMA CELLS; TIME FACTORS; VACCINATION;

EID: 77953742950     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2010.00912.x     Document Type: Review

References (98)

1. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007 357 : 1903 1915.
2. Jerne NK. Idiotypic networks and other preconceived ideas. Immunol Rev 1984 79 : 5 24.
3. MacLennan IC, Casamayor-Palleja M, Toellner KM, Gulbranson-Judge A, Gordon J. Memory B-cell clones and the diversity of their members. Semin Immunol 1997 9 : 229 234.
4. Plotkin SA, Starr SE, Connor K, Morton D. Zoster in normal children after varicella vaccine. J Infect Dis 1989 159 : 1000 1001.
5. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 1991 325 : 1545 1550.
6. Krause PR, Klinman DM. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med 2000 6 : 451 454.
7. Chaves SS, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 2007 356 : 1121 1129.
8. Di Genova G, Roddick J, McNicholl F, Stevenson FK. Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood 2006 107 : 2806 2813.
9. Slifka MK, Ahmed R. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol 1996 4 : 394 400.
10. Slifka MK. Immunological memory to viral infection. Curr Opin Immunol 2004 16 : 443 450.
11. Nanan R, Heinrich D, Frosch M, Kreth HW. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine 2001 20 : 498 504.
12. Bonsignori M, et al. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection. J Immunol 2009 183 : 2708 2717.
13. Hammarlund E, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003 9 : 1131 1137.
14. Taub DD, et al. Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med 2008 121 : 1058 1064.
15. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia - transmission of vaccinia from smallpox vaccination. JAMA 2002 288 : 1901 1905.
16. Sepkowitz KA. How contagious is vaccinia? N Engl J Med 2003 348 : 439 446.
17. Irons JV, Sullivan TD, Cook EBM, Cox GW, Hale RA. Outbreak of smallpox in the lower Rio Grande valley of Texas in 1949. Am J Public Health Nations Health 1953 43 : 25 29.
18. Cummings JF, Polhemus ME, Hawkes C, Klote M, Ludwig GV, Wortmann G. Lack of vaccinia viremia after smallpox vaccination. Clin Infect Dis 2004 38 : 456 458.
19. el-Ad B, et al. The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis 1990 161 : 446 448.
20. Stienlauf S, et al. Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination. Vaccine 1999 17 : 201 204.
21. Frey SE, Newman FK, Yan L, Belshe RB. Response to smallpox vaccine in persons immunized in the distant past. JAMA 2003 289 : 3295 3299.
22. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003 171 : 4969 4973.
23. Putz MM, Alberini I, Midgley CM, Manini I, Montomoli E, Smith GL. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol 2005 86 : 2955 2960.
24. Liu YJ, Grouard G, de Bouteiller O, Banchereau J. Follicular dendritic cells and germinal centers. Int Rev Cytol 1996 166 : 139 179.
25. MacLennan IC. Germinal centers. Annu Rev Immunol 1994 12 : 117 139.
26. Tew JG, Kosco MH, Burton GF, Szakal AK. Follicular dendritic cells as accessory cells. Immunol Rev 1990 117 : 185 211.
27. Tew JG, Mandel TE. Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice. Immunology 1979 37 : 69 76.
28. Kelsoe G. The germinal center: a crucible for lymphocyte selection. Semin Immunol 1996 8 : 179 184.
29. McHeyzer-Williams MG, Ahmed R. B cell memory and the long-lived plasma cell. Curr Opin Immunol 1999 11 : 172 179.
30. Dogan I, et al. Multiple layers of B cell memory with different effector functions. Nat Immunol 2009 10 : 1292 1299.
31. Mandel TE, Phipps RP, Abbot A, Tew JG. The follicular dendritic cell: long term antigen retention during immunity. Immunol Rev 1980 53 : 29 59.
32. Tarlinton D. Germinal centers: form and function. Curr Opin Immunol 1998 10 : 245 251.
33. Bachmann MF, Odermatt B, Hengartner H, Zinkernagel RM. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J Exp Med 1996 183 : 2259 2269.
34. Salomon B, Cohen JL, Masurier C, Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol 1998 160 : 708 717.
35. Kamath AT, et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 2000 165 : 6762 6770.
36. Ruedl C, Koebel P, Bachmann M, Hess M, Karjalainen K. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol 2000 165 : 4910 4916.
37. Vieira P, Rajewsky K. Persistence of memory B cells in mice deprived of T cell help. Int Immunol 1990 2 : 487 494.
38. Hebeis BJ, et al. Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med 2004 199 : 593 602.
39. Puaux AL, et al. A very rapid and simple assay based on trogocytosis to detect and measure specific T and B cell reactivity by flow cytometry. Eur J Immunol 2006 36 : 779 788.
40. Aucher A, Magdeleine E, Joly E, Hudrisier D. Capture of plasma membrane fragments from target cells by trogocytosis requires signaling in T cells but not in B cells. Blood 2008 111 : 5621 5628.
41. Homann D, Teyton L, Oldstone MB. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 2001 7 : 913 919.
42. Amara RR, Nigam P, Sharma S, Liu J, Bostik V. Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J Virol 2004 78 : 3811 3816.
43. Sawyer WA. Persistence of yellow fever immunity. Am J Prev Med 1931 5 : 413 428.
44. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002 298 : 2199 2202.
45. Traggiai E, Puzone R, Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 2003 21 (Suppl. 2 S35 S37.
46. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004 286 : 111 122.
47. Amanna IJ, Slifka MK. Quantitation of rare memory B cell populations by two independent and complementary approaches. J Immunol Methods 2006 317 : 175 185.
48. Benson MJ, et al. Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. J Exp Med 2009 206 : 2013 2025.
49. Richard K, Pierce SK, Song W. The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo. J Immunol 2008 181 : 1746 1752.
50. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007 13 : 552 559.
51. Miller JJ. An autoradiographic study of plasma cell and lymphocyte survival in rat popliteal lymph nodes. J Immunol 1964 92 : 673 681.
52. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997 388 : 133 134.
53. Leyendeckers H, et al. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur J Immunol 1999 29 : 1406 1417.
54. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998 8 : 363 372.
55. DiLillo DJ, et al. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 2008 180 : 361 371.
56. Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci USA 2008 105 : 4802 4807.
57. Cambridge G, et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 2003 48 : 2146 2154.
58. Radbruch A, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006 6 : 741 750.
59. Hill SW. Distribution of plaque-forming cells in the mouse for a protein antigen. Evidence for highly active parathymic lymph nodes following intraperitoneal injection of hen lysozyme. Immunology 1976 30 : 895 906.
60. Benner R, Hijmans W, Haaijman JJ. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol 1981 46 : 1 8.
61. Slifka MK, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995 69 : 1895 1902.
62. Hyland L, Sangster M, Sealy R, Coleclough C. Respiratory virus infection of mice provokes a permanent humoral immune response. J Virol 1994 68 : 6083 6086.
63. Slifka MK, Ahmed R. Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay. J Immunol Methods 1996 199 : 37 46.
64. Taillardet M, et al. The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells. Blood 2009 114 : 4432 4440.
65. Claflin AJ, Smithies O. Antibody-producing cells in division. Science 1967 157 : 1561 1562.
66. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985 314 : 537 539.
67. Nossal GJ. B lymphocyte physiology: the beginning and the end. Ciba Found Symp 1997 204 : 220 230.
68. Takahashi Y, et al. Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-xL transgenic mice. J Exp Med 1999 190 : 399 410.
69. Burton DR. Opinion: antibodies, viruses and vaccines. Nat Rev Immunol 2002 2 : 706 713.
70. Cooper EH. Production of lymphocytes and plasma cells in the rat following immunization with human serum albumin. Immunology 1961 4 : 219 231.
71. Schooley JC. Autoradiographic observations of plasma cell formation. J Immunol 1961 86 : 331 337.
72. Makela O, Nossal GJV. Autoradiographic studies on the immune response. J Exp Med 1962 115 : 231 245.
73. Levy M, Vieira P, Coutinho A, Freitas A. The majority of "natural" immunoglobulin-secreting cells are short-lived and the progeny of cycling lymphocytes. Eur J Immunol 1987 17 : 849 854.
74. Scheiermann N, Kuwert EK. Uptake and elimination of hepatitis B immunoglobulins after intramuscular application in man. Dev Biol Stand 1983 54 : 347 355.
75. Hopkins RJ, et al. Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers. Clin Infect Dis 2004 39 : 759 766.
76. Adner N, Leibl H, Enzersberger O, Kirgios M, Wahlberg T. Pharmacokinetics of human tick-borne encephalitis virus antibody levels after injection with human tick-borne encephalitis immunoglobulin, solvent/detergent treated, FSME-BULIN S/D in healthy volunteers. Scand J Infect Dis 2001 33 : 843 847.
77. Bruss JB, et al. Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin. Pediatr Infect Dis J 1999 18 : 505 511.
78. Ghetie V, Ward ES. Transcytosis and catabolism of antibody. Immunol Res 2002 25 : 97 113.
79. Lee MS, Chien LJ, Yueh YY, Lu CF. Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997. Vaccine 2001 19 : 4644 4651.
80. Herrmann KL, Halstead SB, Wiebenga NH. Rubella antibody persistence after immunization. JAMA 1982 247 : 193 196.
81. Ho F, Lortan JE, MacLennan I, Khan M. Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol 1986 16 : 1297 1301.
82. Conrad RE, Ingraham JS. Rate of hemolytic antibody production by single cells in vivo in rabbits. J Immunol 1974 112 : 17 25.
83. Helmreich E, Kern M, Eisen HN. The secretion of antibody by isolated lymph node cells. J Biol Chem 1961 236 : 464 473.
84. Helmreich E, Kern M, Eisen HN. Observations on the mechanism of secretion of g-globulins by isolated lymph node cells. J Biol Chem 1962 237 : 1925 1931.
85. Hibi T, Dosch HM. Limiting dilution analysis of the B cell compartment in human bone marrow. Eur J Immunol 1986 16 : 139 145.
86. Tokoyoda K, Zehentmeier S, Chang HD, Radbruch A. Organization and maintenance of immunological memory by stroma niches. Eur J Immunol 2009 39 : 2095 2099.
87. Cassese G, et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 2003 171 : 1684 1690.
88. Hauser AE, et al. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol 2002 169 : 1277 1282.
89. Hargreaves DC, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001 194 : 45 56.
90. Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, Zou YR. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med 2004 200 : 1145 1156.
91. Kallies A, Nutt SL. Terminal differentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol 2007 19 : 156 162.
92. Shapiro-Shelef M, Lin KI, Savitsky D, Liao J, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med 2005 202 : 1471 1476.
93. Martins G, Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008 26 : 133 169.
94. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009 9 : 491 502.
95. O'Connor BP, et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004 199 : 91 98.
96. Benson MJ, et al. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 2008 180 : 3655 3659.
97. Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. SAP is required for generating long-term humoral immunity. Nature 2003 421 : 282 287.
98. Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 2008 455 : 764 769.